Integrative analysis reveals clinically relevant molecular fingerprints in pancreatic cancer

Pancreatic cancer is a highly aggressive cancer with an exceedingly low rate of response to treatments, which calls for comprehensive molecular characterization of pancreatic cancer cell lines (PCCLs). We screened multi-layer molecular data of 36 PCCLs, including gene mutation, gene expression, micr...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Libin, Qi, Simin, Hu, Wei, Fang, Zhixiao, Yu, Dehua, Liu, Teng, Wu, Jingni, Wu, Yangjun, Wu, Aiwei, Feng, Lanyun, Xie, Jing, Zhang, Bo, He, Wenguang, Ning, Zhouyu, Liu, Luming, Qin, Jiang-Jiang, Li, Shengli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408433/
https://www.ncbi.nlm.nih.gov/pubmed/34513290
http://dx.doi.org/10.1016/j.omtn.2021.06.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408433/
https://www.ncbi.nlm.nih.gov/pubmed/34513290
http://dx.doi.org/10.1016/j.omtn.2021.06.015

Ejemplares similares